Neurology

New results from the Phase III TEMPO-2 trial, presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, indicate that flexible-dose tavapadon significantly improved motor symptoms and daily functioning in adults with early Parkinson’s disease (PD), compared with placebo.

In hospitalized patients with alcohol withdrawal syndrome (AWS), early addition of phenobarbital to lorazepam-based treatment significantly reduces the length of stay and the need for mechanical ventilation compared to dexmedetomidine, according to a new retrospective study conducted in a U.S. tertiary hospital.

At the 2025 American Academy of Neurology (AAN) Annual Meeting, researchers presented compelling new data showing a sharp increase in hospitalizations for cervical artery dissection, a potentially life-threatening cause of stroke, particularly in adults under 50.

The menstrual cycle significantly impacts women’s emotional decision-making and cognitive processing, according to a new EEG study examining approach-avoidance behaviors across different hormonal phases.

Light-to-moderate alcohol consumption may contribute to increased amyloid beta (Aβ) deposition, a hallmark biomarker of Alzheimer’s disease, according to new findings from the ALBION study.

A chronic stroke aphasia study has revealed that significant language recovery can occur even after the initial recovery phase, providing hope for patients who might otherwise feel that recovery is no longer possible.

Neuropsychiatric symptoms are highly prevalent in sporadic Creutzfeldt-Jakob disease (sCJD), with nearly all patients exhibiting behavioral changes early in the disease course, according to a recent study.

A study using machine learning has identified dynapenia, age-related muscle weakness, as a critical but overlooked risk factor for atherosclerotic cardiovascular disease (ASCVD), particularly in females.